“The delay on the Tagrisso drug price negotiation is no special treatment”

While the drug price negotiation for ‘Tagrisso,’ a non-small cell lung cancer treatment, has made various issues, the National Health Insurance Service(NHIS) clarified them.

In a statement of clarifying them on the 26^th, the NHIS said “We are carrying out the negotiation fairly under the drug price negotiation guideline in consideration of various factors, such as the drug’s price in other cou...